These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27720377)

  • 41. Rapid diagnosis of new and relapse tuberculosis by quantification of a circulating antigen in HIV-infected adults in the Greater Houston metropolitan area.
    Fan J; Zhang H; Nguyen DT; Lyon CJ; Mitchell CD; Zhao Z; Graviss EA; Hu Y
    BMC Med; 2017 Nov; 15(1):188. PubMed ID: 29089034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the Traditional Chinese Medicine Syndromes of tuberculosis.
    Liu J; Li Y; Wei L; Yang X; Xie Z; Jiang T; Wang C; Zhang X; Xu D; Chen Z; Yang F; Li JC
    J Ethnopharmacol; 2014 Sep; 155(2):1322-31. PubMed ID: 25072359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Depressed Gamma Interferon Responses and Treatment Outcomes in Tuberculosis Patients: a Prospective Cohort Study.
    Feng JY; Pan SW; Huang SF; Chen YY; Lin YY; Su WJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30068533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
    Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK
    BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy.
    Nagu T; Aboud S; Rao M; Matee M; Axelsson R; Valentini D; Mugusi F; Zumla A; Maeurer M
    Int J Infect Dis; 2017 Mar; 56():136-139. PubMed ID: 28193504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative analysis of whole-blood interferon-γ and flow cytometry assays for detecting post-treatment immune responses in patients with active tuberculosis.
    Kim CH; Choi KJ; Yoo SS; Lee SY; Won DI; Lim JO; Cha SI; Park JY; Lee J
    Cytometry B Clin Cytom; 2014 Jul; 86(4):236-43. PubMed ID: 23959689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
    Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment.
    Jacobs R; Tshehla E; Malherbe S; Kriel M; Loxton AG; Stanley K; van der Spuy G; Walzl G; Chegou NN
    Cytokine; 2016 May; 81():50-6. PubMed ID: 26878648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.
    Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
    J Infect; 2009 Mar; 58(3):197-204. PubMed ID: 18848730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A rapid and low-cost microscopic observation drug susceptibility assay for detecting TB and MDR-TB among individuals infected by HIV in South India.
    Solomon S; Balakrishnan P; Vignesh R; Waldrop G; Solomon SS; Murugavel KG; Kumarasamy N; Yepthomi T; Poongulali S; Swathirajan CR; Sreenivasan V; Chandrasekar C; Suriakumar J; Mahilmaran A; Manoharan G; Moore DA
    Indian J Med Microbiol; 2013; 31(2):130-7. PubMed ID: 23867668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
    Friedrich SO; Rachow A; Saathoff E; Singh K; Mangu CD; Dawson R; Phillips PP; Venter A; Bateson A; Boehme CC; Heinrich N; Hunt RD; Boeree MJ; Zumla A; McHugh TD; Gillespie SH; Diacon AH; Hoelscher M;
    Lancet Respir Med; 2013 Aug; 1(6):462-70. PubMed ID: 24429244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy.
    Ahmed MIM; Ntinginya NE; Kibiki G; Mtafya BA; Semvua H; Mpagama S; Mtabho C; Saathoff E; Held K; Loose R; Kroidl I; Chachage M; von Both U; Haule A; Mekota AM; Boeree MJ; Gillespie SH; Hoelscher M; Heinrich N; Geldmacher C
    Front Immunol; 2018; 9():2247. PubMed ID: 30323818
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical Presentation, treatment outcome and survival among the HIV infected children with culture confirmed tuberculosis.
    Kumar A; Upadhyay S; Kumari G
    Curr HIV Res; 2007 Sep; 5(5):499-504. PubMed ID: 17896970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. False-Positive Xpert MTB/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical Outcomes.
    Theron G; Venter R; Smith L; Esmail A; Randall P; Sood V; Oelfese S; Calligaro G; Warren R; Dheda K
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29305538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.
    Goodridge A; Cueva C; Lahiff M; Muzanye G; Johnson JL; Nahid P; Riley LW
    Tuberculosis (Edinb); 2012 May; 92(3):243-7. PubMed ID: 22406155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection.
    Tonby K; Ruhwald M; Kvale D; Dyrhol-Riise AM
    Sci Rep; 2015 Mar; 5():9223. PubMed ID: 25783975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.
    Chien JY; Chen YT; Shu CC; Lee JJ; Wang JY; Yu CJ; Yang PC
    Chest; 2013 Jun; 143(6):1725-1732. PubMed ID: 23288018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indicators for prediction of Mycobacterium tuberculosis positivity detected with bronchoalveolar lavage fluid.
    Liu X; Hou XF; Gao L; Deng GF; Zhang MX; Deng QY; Ye TS; Yang QT; Zhou BP; Wen ZH; Liu HY; Kornfeld H; Chen XC
    Infect Dis Poverty; 2018 Mar; 7(1):22. PubMed ID: 29580276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.